MacroGenics, Inc.
MACROGENICS INC (Form: SC 13G/A, Received: 11/06/2017 16:54:35)

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No. 1)*

 

 

MACROGENICS, INC.

(Name of Issuer)

Common Stock, par value $0.01 per share

(Title of Class of Securities)

556099109

(CUSIP Number)

September 21, 2017

(Date of Event which Requires Filing of this Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☐ Rule 13d-1(b)

☒ Rule 13d-1(c)

☐ Rule 13d-1(d)

 

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 


CUSIP No. 556099109  

 

  1   

Names of reporting persons.

 

Boxer Capital, LLC

  2  

Check the appropriate box if a member of a group. (See instructions)

(a)  ☐        (b)  ☒

 

  3  

SEC use only.

 

  4  

Citizenship or place of organization.

 

Delaware

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH:

     

Sole voting power .

 

-0-

   6   

Shared voting power .

 

2,200,000

   7   

Sole dispositive power.

 

-0-

   8   

Shared dispositive power.

 

2,200,000

  9  

Aggregate amount beneficially owned by each reporting person.

 

2,200,000

10  

Check box if the aggregate amount in row (9) excludes certain shares (see instructions).

 

11  

Percent of class represented by amount in row (9).

 

6.0%*

12  

Type of reporting person.

 

OO

 

* Based on 36,798,465 shares of common stock reported to be outstanding as of July 31, 2017 on the Issuer’s quarterly report on Form 10-Q filed with the Securities and Exchange Commission on August 2, 2017.


CUSIP No. 556099109  

 

  1   

Names of reporting persons.

 

Boxer Asset Management Inc.

  2  

Check the appropriate box if a member of a group. (See instructions)

(a)  ☐        (b)  ☒

 

  3  

SEC use only.

 

  4  

Citizenship or place of organization.

 

Bahamas

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH:

     

Sole voting power .

 

-0-

   6   

Shared voting power .

 

2,200,000

   7   

Sole dispositive power.

 

-0-

   8   

Shared dispositive power.

 

2,200,000

  9  

Aggregate amount beneficially owned by each reporting person.

 

2,200,000

10  

Check box if the aggregate amount in row (9) excludes certain shares (see instructions).

 

11  

Percent of class represented by amount in row (9).

 

6.0%*

12  

Type of reporting person.

 

CO

 

* Based on 36,798,465 shares of common stock reported to be outstanding as of July 31, 2017 on the Issuer’s quarterly report on Form 10-Q filed with the Securities and Exchange Commission on August 2, 2017.


CUSIP No. 556099109  

 

  1   

Names of reporting persons.

 

Braslyn Ltd.

  2  

Check the appropriate box if a member of a group. (See instructions)

(a)  ☐        (b)  ☒

 

  3  

SEC use only.

 

  4  

Citizenship or place of organization.

 

Bahamas

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH:

     

Sole voting power .

 

-0-

   6   

Shared voting power .

 

323,223

   7   

Sole dispositive power.

 

-0-

   8   

Shared dispositive power.

 

323,223

  9  

Aggregate amount beneficially owned by each reporting person.

 

323,223

10  

Check box if the aggregate amount in row (9) excludes certain shares (see instructions).

 

11  

Percent of class represented by amount in row (9).

 

0.9%*

12  

Type of reporting person.

 

OO

 

* Based on 36,798,465 shares of common stock reported to be outstanding as of July 31, 2017 on the Issuer’s quarterly report on Form 10-Q filed with the Securities and Exchange Commission on August 2, 2017.


CUSIP No. 556099109  

 

  1   

Names of reporting persons.

 

Joe Lewis

  2  

Check the appropriate box if a member of a group. (See instructions)

(a)  ☐        (b)  ☒

 

  3  

SEC use only.

 

  4  

Citizenship or place of organization.

 

United Kingdom

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH:

     

Sole voting power .

 

-0-

   6   

Shared voting power .

 

2,523,223

   7   

Sole dispositive power.

 

-0-

   8   

Shared dispositive power.

 

2,523,223

  9  

Aggregate amount beneficially owned by each reporting person.

 

2,523,223

10  

Check box if the aggregate amount in row (9) excludes certain shares (see instructions).

 

11  

Percent of class represented by amount in row (9).

 

6.9%*

12  

Type of reporting person.

 

IN

 

* Based on 36,798,465 shares of common stock reported to be outstanding as of July 31, 2017 on the Issuer’s quarterly report on Form 10-Q filed with the Securities and Exchange Commission on August 2, 2017.


This Amendment No. 1 (“Amendment No. 1”) amends and supplements the statement on Schedule 13G initially filed on June 12, 2017 (the “Original Filing”) by Boxer Capital, LLC (“Boxer Capital”), Boxer Asset Management Inc. (“Boxer Management”), and Joe Lewis. This Amendment No. 1 is an original filing for Braslyn Ltd. (“Braslyn,” together with Boxer Capital, Boxer Management and Joe Lewis, the “Reporting Persons”). The Original Filing remains in effect except to the extent that it is amended, restated or superseded by information contained in this Amendment No. 1. Capitalized terms used and not defined in this Amendment No. 1 have the meanings set forth in the Original Filing.

 

Item 1(a). Name of Issuer:

Macrogenics, Inc. (the “Issuer”)

 

Item 1(b). Address of Issuer’s Principal Executive Offices:

9704 Medical Center Drive

Rockville, MD 20850

 

Item 2(a). Name of Person Filing:

This Schedule 13G is jointly filed by Boxer Capital, LLC (“Boxer Capital”), Boxer Asset Management Inc. (“Boxer Management”), Braslyn Ltd. (“Braslyn”) and Joe Lewis (together with Boxer Capital, Boxer Management and Brasyln, the “Reporting Persons”). Boxer Management is the managing member and majority owner of Boxer Capital. Joe Lewis is the sole indirect beneficial owner of and controls Boxer Management and Braslyn.

 

Item 2(b). Address of Principal Business Office, or, if none, Residence:

The principal business address of Boxer Capital is: 11682 El Camino Real, Suite 320, San Diego, CA 92130. The principal business address of Boxer Management, Braslyn and Joe Lewis is: Cay House, EP Taylor Drive N7776, Lyford Cay, New Providence, Bahamas.

 

Item 2(c). Citizenship:

Boxer Capital is a limited liability company organized under the laws of Delaware. Boxer Management is a corporation organized under the laws of the Bahamas. Braslyn is a corporation organized under the laws of the Bahamas. Joe Lewis is a citizen of the United Kingdom.

 

Item 2(d). Title of Class of Securities:

Common Stock, par value $0.01 per share (the “Common Stock”).

 

Item 2(e). CUSIP Number:

556099109

 

Item 3. If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:

Not applicable.

 

Item 4. Ownership.

 

  (a) Amount beneficially owned:

Boxer Capital and Boxer Management beneficially own 2,200,000 shares of Common Stock. Braslyn beneficially owns 323,223 shares of Common Stock. Joe Lewis beneficially owns 2,523,223 shares of Common Stock. The Reporting Persons may be deemed to beneficially own 2,523,223 shares of Common Stock in the aggregate.


  (b) Percent of class:

The shares of Common Stock beneficially owned by Boxer Capital and Boxer Management represent 6.0%* of the Issuer’s outstanding shares of Common Stock. The shares of Common Stock beneficially owned by Braslyn represent 0.9%* of the Issuer’s outstanding shares of Common Stock. The shares of Common Stock beneficially owned by Joe Lewis represent 6.9%* of the Issuer’s outstanding shares of Common Stock. The shares of Common Stock that may be deemed to be beneficially owned by the Reporting Persons in the aggregate represent 6.9% of the Issuer’s outstanding shares of Common Stock.

 

  (c) Number of shares as to which such person has:

 

  (i) Sole power to vote or direct the vote:

None of the Reporting Persons has the sole power to vote or to direct the vote of any shares of Common Stock the Reporting Persons beneficially own.

 

  (ii) Shared power to vote or to direct the vote:

Boxer Capital and Boxer Management have shared power to vote or to direct the vote of the 2,200,000 shares of Common Stock they beneficially own. Braslyn has shared power to vote or to direct the vote of the 323,223 shares of Common Stock it beneficially owns. Joe Lewis has shared power to vote or to direct the vote of the 2,523,223 shares of Common Stock he beneficially owns.

 

  (iii) Sole power to dispose or to direct the disposition of:

None of the Reporting Persons has the sole power to dispose or to direct the disposition of any of the shares of Common Stock the Reporting Persons beneficially own.

 

  (iv) Shared power to dispose or to direct the disposition of:

Boxer Capital and Boxer Management have shared power to dispose or direct the disposition of the 2,200,000 shares of Common Stock they beneficially own. Braslyn has shared power to dispose or direct the disposition of the 323,223 shares of Common Stock it beneficially owns. Joe Lewis has shared power to dispose or direct the disposition of the 2,523,223 shares of Common Stock he beneficially owns.

 

* Based on 36,798,465 shares of Common Stock reported to be outstanding as of July 31, 2017 on the Issuer’s quarterly report on Form 10-Q filed with the Securities and Exchange Commission on August 2, 2017.

 

Item 5. Ownership of Five Percent or Less of a Class.

Not applicable.

 

Item 6. Ownership of More than Five Percent on Behalf of Another Person.

Only Boxer Capital has the right to receive dividends and the proceeds from the sale of the shares of Common Stock held by Boxer Capital. Only Braslyn has the right to receive dividends and the proceeds from sale of the shares of Common Stock held by Braslyn. See Item 4 above.

 

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

Not applicable.

 

Item 8. Identification and Classification of Members of the Group.

Not applicable.

 

Item 9. Notice of Dissolution of Group.

Not applicable.


Item 10. Certification.

(c) By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

Exhibits

 

1 Joint Filing Agreement, dated November 6, 2017, among the Reporting Persons.


SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

November 6, 2017

 

BOXER CAPITAL, LLC
By:  

/s/ Aaron I. Davis

Name:   Aaron I. Davis
Title:   Chief Executive Officer
BOXER ASSET MANAGEMENT INC.
By:  

/s/ Jason Callender

Name:   Jason Callender
Title:   Director
BRASLYN LTD.
By:  

/s/ Jason Callender

Name:   Jason Callender
Title:   Director
JOSEPH C. LEWIS

/s/ Joseph C. Lewis

Joseph C. Lewis, Individually

Exhibit 1

JOINT FILING AGREEMENT

The undersigned hereby agree that the Statement on Schedule 13G with respect to the shares of Macrogenics, Inc., Common Stock, par value $0.01 per share, is, and any amendments thereto executed by each of us shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, and that this Agreement shall be included as an Exhibit to the Schedule 13G and each such amendment. Each of the undersigned agrees to be responsible for the timely filing of the Schedule 13G and any amendments thereto, and for the completeness and accuracy of the information concerning itself contained therein. This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.

IN WITNESS WHEREOF, the undersigned have executed this Agreement as of November 6, 2017.

 

BOXER CAPITAL, LLC
By:  

/s/ Aaron I. Davis

Name:   Aaron I. Davis
Title:   Chief Executive Officer
BOXER ASSET MANAGEMENT INC.
By:  

/s/ Jason Callender

Name:   Jason Callender
Title:   Director
BRASLYN LTD.
By:  

/s/ Jason Callender

Name:   Jason Callender
Title:   Director
JOSEPH C. LEWIS

/s/ Joseph C. Lewis

Joseph C. Lewis, Individually